用于过敏治疗的类过敏原。

IF 4.2 Q3 Pharmacology, Toxicology and Pharmaceutics
Jeronimo Carnes, Maria T Gallego, Raquel Moya, Victor Iraola
{"title":"用于过敏治疗的类过敏原。","authors":"Jeronimo Carnes,&nbsp;Maria T Gallego,&nbsp;Raquel Moya,&nbsp;Victor Iraola","doi":"10.2174/1872213X12666180221155908","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chemically modified allergen extracts, known as allergoids, are commonly used for treating allergic patients. In general terms, the concept of allergoids implies allergen extracts with a reduction of their allergenicity maintaining their immunogenicity. Different methods to obtain allergoids have been developed in the past years, opening attractive lines of research.</p><p><strong>Objective: </strong>To review the different approaches to allergoid development as well as their characterization, mechanism of action and efficacy and safety issues.</p><p><strong>Methods: </strong>A revision and analysis of the different types of allergoids has been performed, with special attention to patents submitted and granted in the last years. Additionally, updated information about the mechanism of action and clinical evidence and safety of allergoids has been discussed.</p><p><strong>Results: </strong>Principally, allergoids are obtained by the polymerization of native allergen extracts with aldehydes, including formaldehyde or glutaraldehyde. However, recent patents and publications about different chemical modifications have been presented, as well as about the use of new adjuvants with allergoids. Regarding the characterization, allergoids require more sophisticated analytical methods than native extracts, as a consequence of their properties and characteristics.</p><p><strong>Conclusion: </strong>In the last years, the partial understanding of the mechanism of action and the generation of clinical evidence of different types of allergoids, linked to their excellent safety profile and their convenience for a quick build up phase, have made of allergoids an excellent product for allergy treatment.</p>","PeriodicalId":20960,"journal":{"name":"Recent patents on inflammation & allergy drug discovery","volume":"12 2","pages":"110-119"},"PeriodicalIF":4.2000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"10","resultStr":"{\"title\":\"Allergoids for Allergy Treatment.\",\"authors\":\"Jeronimo Carnes,&nbsp;Maria T Gallego,&nbsp;Raquel Moya,&nbsp;Victor Iraola\",\"doi\":\"10.2174/1872213X12666180221155908\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chemically modified allergen extracts, known as allergoids, are commonly used for treating allergic patients. In general terms, the concept of allergoids implies allergen extracts with a reduction of their allergenicity maintaining their immunogenicity. Different methods to obtain allergoids have been developed in the past years, opening attractive lines of research.</p><p><strong>Objective: </strong>To review the different approaches to allergoid development as well as their characterization, mechanism of action and efficacy and safety issues.</p><p><strong>Methods: </strong>A revision and analysis of the different types of allergoids has been performed, with special attention to patents submitted and granted in the last years. Additionally, updated information about the mechanism of action and clinical evidence and safety of allergoids has been discussed.</p><p><strong>Results: </strong>Principally, allergoids are obtained by the polymerization of native allergen extracts with aldehydes, including formaldehyde or glutaraldehyde. However, recent patents and publications about different chemical modifications have been presented, as well as about the use of new adjuvants with allergoids. Regarding the characterization, allergoids require more sophisticated analytical methods than native extracts, as a consequence of their properties and characteristics.</p><p><strong>Conclusion: </strong>In the last years, the partial understanding of the mechanism of action and the generation of clinical evidence of different types of allergoids, linked to their excellent safety profile and their convenience for a quick build up phase, have made of allergoids an excellent product for allergy treatment.</p>\",\"PeriodicalId\":20960,\"journal\":{\"name\":\"Recent patents on inflammation & allergy drug discovery\",\"volume\":\"12 2\",\"pages\":\"110-119\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recent patents on inflammation & allergy drug discovery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1872213X12666180221155908\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent patents on inflammation & allergy drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1872213X12666180221155908","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 10

摘要

背景:化学修饰的过敏原提取物,被称为类过敏原,通常用于治疗过敏患者。一般来说,类过敏原的概念意味着过敏原提取物的过敏原性降低,保持其免疫原性。在过去的几年里,获得类过敏原的不同方法得到了发展,开辟了有吸引力的研究方向。目的:综述类过敏原发展的不同途径及其特点、作用机制、疗效和安全性问题。方法:对不同类型的类过敏原进行修订和分析,并特别关注最近几年提交和授予的专利。此外,还讨论了有关类过敏原的作用机制、临床证据和安全性的最新信息。结果:主要是由天然过敏原提取物与醛(包括甲醛或戊二醛)聚合得到的类过敏原。然而,最近的专利和出版物已经提出了不同的化学修饰,以及使用新的佐剂与类过敏原。在表征方面,由于其性质和特征,类过敏原需要比天然提取物更复杂的分析方法。结论:近年来,对不同类型的类过敏原作用机制的部分了解和临床证据的产生,以及它们良好的安全性和快速建立阶段的便性,使类过敏原成为治疗过敏的优秀产品。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Allergoids for Allergy Treatment.

Background: Chemically modified allergen extracts, known as allergoids, are commonly used for treating allergic patients. In general terms, the concept of allergoids implies allergen extracts with a reduction of their allergenicity maintaining their immunogenicity. Different methods to obtain allergoids have been developed in the past years, opening attractive lines of research.

Objective: To review the different approaches to allergoid development as well as their characterization, mechanism of action and efficacy and safety issues.

Methods: A revision and analysis of the different types of allergoids has been performed, with special attention to patents submitted and granted in the last years. Additionally, updated information about the mechanism of action and clinical evidence and safety of allergoids has been discussed.

Results: Principally, allergoids are obtained by the polymerization of native allergen extracts with aldehydes, including formaldehyde or glutaraldehyde. However, recent patents and publications about different chemical modifications have been presented, as well as about the use of new adjuvants with allergoids. Regarding the characterization, allergoids require more sophisticated analytical methods than native extracts, as a consequence of their properties and characteristics.

Conclusion: In the last years, the partial understanding of the mechanism of action and the generation of clinical evidence of different types of allergoids, linked to their excellent safety profile and their convenience for a quick build up phase, have made of allergoids an excellent product for allergy treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
0
期刊介绍: Recent Patents on Inflammation & Allergy Drug Discovery publishes review articles by experts on recent patents in the field of inflammation and allergy drug discovery e.g. on novel bioactive compounds, analogs and targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in inflammation and allergy drug design and discovery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信